Generex Biotechnology Corp (GNBT) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Apr 30 2021 to Apr 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Generex Biotechnology Corp  (GNBT)


Generex Biotechnology's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Generex Biotechnology's ROI in the third quarter of 2021?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Generex Biotechnology Corp's return on investment (ROI) in its third quarter of 2021

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Apr 30 2021)
III. Quarter		 (Jan 31 2021)
II. Quarter		 (Oct 31 2020)
I. Quarter		 (Jul 31 2020)
IV. Quarter		 (Apr 30 2020)
III. Quarter
Y / Y Investment Change TTM - -90.83 % -65.02 % -15.69 % 132.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -18 -13 -5 5 24
Return On Investment (TTM) - - - -136.32 % -80.6 %
GNBT's Overall Ranking # # # # #
Seq. Investment Change TTM - -79.25 % -40.13 % -22.11 % -5.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -37 -51 -33 -28 -21

GNBT Company Profile >> Back to GNBT Roi Comparisons >> See Annual GNBT Return On Investment



Return On Investment GNBT's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Generex Biotechnology's III. Quarter Investments $ -18 Millions GNBT's Balance sheet
Generex Biotechnology's III. Quarter Income $ 8 Millions Quarterly GNBT's Income Statement
GNBT's Income by Division See GNBT's Income by Division


GNBT Annual Return On Investment (Jul 31 2020)
2020		 (Jul 31 2019)
2019		 (Jul 31 2018)
2018		 (Jul 31 2017)
2017		 (Jul 31 2016)
2016
Total Investments in Millions 5 28 -24 -19 -9
Y / Y Investment Growth -83.54 % - - - -
Net Income in Millions -32 -8 37 -63 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment -705.37 % -27.48 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GNBT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GNBT's Competitors
Subscribers only: Roi for Generex Biotechnology's Suppliers
Subscribers only: Return On Investment for GNBT's Customers

Other Ratios
GNBT's Roa GNBT's Inventory Turnover Ratio GNBT's Growth Rates GNBT's Dividend Statistics
GNBT's Profitability Ratios GNBT's Asset Turnover Ratio GNBT's Dividend Growth
GNBT's Roe GNBT's Valuation Ratios GNBT's Financial Strength Ratios GNBT's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2021, within Healthcare Sector ROI
Tenax Therapeutics Inc   663.34 %
Ethema Health Corporation   524.84 %
Vyne Therapeutics Inc   241.31 %
Biodesix Inc   159.19 %
Agios Pharmaceuticals Inc   129.54 %
Ovid Therapeutics Inc   121.25 %
Pulmonx Corporation  120.38 %
Dyne Therapeutics Inc   107.78 %
Fulgent Genetics Inc   100.97 %
Alpha Pro Tech Ltd   99.81 %
Reflect Scientific Inc  99.19 %

Date modified: 2026-06-22T14:32:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.